直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

Innovation Liberation

September 2020

Intellectual Property Magazine

By Linda J. Thayer

Despite Covid-19, patent filings during the first three months of the pandemic actually increased in the US.1 But if your company hit the pause button on patenting, how do you catch up?

Provisional Patent Applications

Passing the America Invents Act (AIA) in 2013, the US joined the rest of the world in the race to patent. Even during a pandemic, the applicant that files first will receive priority over all others. No special pandemic rules change this. If you or your company cannot afford full application drafting and filing costs now, filing a provisional application for $280 ($140 for small entities), often with existing internal documents drafted by your own engineers, allows you to stake out your place in line and provides you with a one-year grace period to continue innovating, analysing the market, and developing a worldwide patenting strategy before committing larger sums of money. Well-written provisional applications may attract investors and funding while protecting your ownership in your ideas. Consulting a patent attorney or agent at some point before filing is recommended.

Read the full article here. 

Tags

COVID-19

Downloadable Files

  • PUBLISHED - Intellectual Property Magazine - Innovation Liberati

Related Practices

Patent Drafting and Prosecution

Related Offices

Boston, MA

Originally printed in Intellectual Property Magazine in the September 2020 edition. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.

Related Insights

Conference

ChIPs Global Summit 2026

October 21-23, 2026

Los Angeles

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Charitable

2026 National Inventors Hall of Fame Induction Ceremony

May 7, 2026

Washington, DC

Conference

THRiVE 2026

April 30, 2026

Richmond

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP